Title:
【発明の名称】アミジノ化合物、それらの製造および治療方法
Document Type and Number:
Japanese Patent JP3370998
Kind Code:
B2
Abstract:
The invention relates to the compounds of the formula and pharmaceutically acceptable salts thereof, in which: R1 is amino which is mono- or disubstituted by a substituent selected from an aliphatic hydrocarbon radical, an araliphatic hydrocarbon radical, an aromatic radical, and a cycloaliphatic hydrocarbon radical or is amino which is disubstituted by a divalent aliphatic hydrocarbon radical; R2 is hydrogen, halogen, trifluoromethyl, an aliphatic hydrocarbon radical, or is hydroxy which is etherified by an aliphatic alcohol, araliphatic alcohol, or aromatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; R3 is hydrogen or an acyl radical which is derived from an organic carbonic acid, un organic carboxylic acid, a sulfonic acid, or a carbamic acid; X1 and X3, independently of one another, are oxygen (-O-) or sulphur (-S-); and X2 is a divalent aliphatic hydrocarbon radical which may be interrupted by an aromatic radical; wherein the phenyl rings of formula I may be, independently of one another, further substituted by one or more substituents selected from halogen, trifluoromethyl, un aliphatic hydrocarbon radical, hydroxy, and hydroxy which is etherified by an aliphatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; wherein aryl in the above definitions may be, independently of one another, further substituted by one or more substituents selected from halogen, trifluoromethyl, un aliphatic hydrocarbon radical, hydroxy, and hydroxy which is etherified by an aliphatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; wherein a cycloaliphatic hydrocarbon radical may be substituted by an aliphatic radical. The compounds are useful as selective LTB-4 receptor antagonists in the treatment of conditions or syndromes in mammals which are responsive to LTB-4 receptor antagonism.
Inventors:
Michael M. Maurice
Application Number:
JP14733392A
Publication Date:
January 27, 2003
Filing Date:
June 08, 1992
Export Citation:
Assignee:
Novartis Actien Gezel Shaft
International Classes:
A61K31/085; A61K31/165; A61K31/166; A61K31/17; A61K31/18; A61P7/00; A61P9/08; A61P9/10; A61P11/00; A61P29/00; A61P37/08; A61P43/00; C07C257/10; C07C257/18; C07C257/20; C07C271/64; C07C275/56; C07C303/32; C07C309/04; C07C311/51; A61K31/16; C07C319/18; C07C323/62; C07C323/63; (IPC1-7): C07C257/18; A61K31/166; A61K31/17; A61K31/18; A61P7/00; A61P9/10; A61P11/00; A61P29/00; A61P37/08; A61P43/00; C07C257/20; C07C271/64; C07C275/56; C07C303/32; C07C309/04; C07C311/51; C07C319/18; C07C323/62; C07C323/63
Domestic Patent References:
| JP60163852A |
Attorney, Agent or Firm:
Aoki Akira (3 outside)